E. O. Fedorovskaya

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
According to data in the literature interferon inducers can inhibit tumor metastasization [3]. However, the clinical use of standard interferon inducers (for example, polyl:C) is difficult because of their toxicity and high cost. Interferon-inducing activity has more recently been discovered among certain vasodilators widely used in cardiologic practice(More)
  • 1